https://lifescivoice.com/moderna-passes-phase-2-safety-review-for-mrna-respiratory-syncytial-virus-rsv-vaccine/ Life Sciences Voice | The leading resource for life sciences industry executives. Tue, 01 Mar 2022 06:15:02 +0000 hourly 1 https://wordpress.org/?v=6.8.1